Literature DB >> 10910098

p53-mediated differentiation of the erythroleukemia cell line K562.

K Chylicki1, M Ehinger, H Svedberg, G Bergh, I Olsson, U Gullberg.   

Abstract

The tumor suppressor gene p53 can mediate both apoptosis and cell cycle arrest. In addition, p53 also influences differentiation. To further characterize the differentiation inducing properties of p53, we overexpressed a temperature-inducible p53 mutant (ptsp53Val135) in the erythroleukemia cell line K562. The results show that wild-type p53 and hemin synergistically induce erythroid differentiation of K562 cells, indicating that p53 plays a role in the molecular regulation of differentiation. However, wild-type p53 did not affect phorbol 12-myristate 13-acetate-dependent appearance of the megakaryocyte-related cell surface antigens CD9 and CD61, suggesting that p53 does not generally affect phenotypic modulation. The cyclin-dependent kinase inhibitor p21, a transcriptional target of p53, halts the cell cycle in G1 and has also been implicated in the regulation of differentiation and apoptosis. However, transiently overexpressed p21 did neither induce differentiation nor affect the cell cycle distribution or viability of K562 cells, suggesting that targets downstream of p53 other than p21 are critical for the p53-mediated differentiation response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910098

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  10 in total

1.  Tumor suppressor protein p53 regulates megakaryocytic polyploidization and apoptosis.

Authors:  Peter G Fuhrken; Pani A Apostolidis; Stephan Lindsey; William M Miller; Eleftherios T Papoutsakis
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

2.  A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies.

Authors:  Steffen Boettcher; Peter G Miller; Rohan Sharma; Marie McConkey; Matthew Leventhal; Andrei V Krivtsov; Andrew O Giacomelli; Waihay Wong; Jesi Kim; Sherry Chao; Kari J Kurppa; Xiaoping Yang; Kirsten Milenkowic; Federica Piccioni; David E Root; Frank G Rücker; Yael Flamand; Donna Neuberg; R Coleman Lindsley; Pasi A Jänne; William C Hahn; Tyler Jacks; Hartmut Döhner; Scott A Armstrong; Benjamin L Ebert
Journal:  Science       Date:  2019-08-09       Impact factor: 47.728

3.  Proposed megakaryocytic regulon of p53: the genes engaged to control cell cycle and apoptosis during megakaryocytic differentiation.

Authors:  Pani A Apostolidis; Stephan Lindsey; William M Miller; Eleftherios T Papoutsakis
Journal:  Physiol Genomics       Date:  2012-05-01       Impact factor: 3.107

4.  The p53/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours.

Authors:  Sylwia Ammoun; Marei Caroline Schmid; Lu Zhou; David A Hilton; Magdalena Barczyk; Clemens Oliver Hanemann
Journal:  Mol Oncol       Date:  2014-08-27       Impact factor: 6.603

5.  Identification of novel p53-binding proteins by biomolecular interaction analysis combined with tandem mass spectrometry.

Authors:  Jiro Kikuchi; Yusuke Furukawa; Nakanobu Hayashi
Journal:  Mol Biotechnol       Date:  2003-03       Impact factor: 2.860

6.  Knockdown of ZNF268, which is transcriptionally downregulated by GATA-1, promotes proliferation of K562 cells.

Authors:  Yan Zeng; Wei Wang; Jian Ma; Xianguo Wang; Mingxiong Guo; Wenxin Li
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

7.  A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia.

Authors:  Xueqing Jiang; Lin Sun; Jihui Julia Qiu; Xiujing Sun; Sen Li; Xiyin Wang; Chi Wai Eric So; Shuo Dong
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

8.  Altered translation of GATA1 in Diamond-Blackfan anemia.

Authors:  Leif S Ludwig; Hanna T Gazda; Jennifer C Eng; Stephen W Eichhorn; Prathapan Thiru; Roxanne Ghazvinian; Tracy I George; Jason R Gotlib; Alan H Beggs; Colin A Sieff; Harvey F Lodish; Eric S Lander; Vijay G Sankaran
Journal:  Nat Med       Date:  2014-06-22       Impact factor: 53.440

9.  Effect of Ocimum sanctum extract on leukemic cell lines: A preliminary in-vitro study.

Authors:  M Harsha; K P Mohan Kumar; Santosh Kagathur; Vikram S Amberkar
Journal:  J Oral Maxillofac Pathol       Date:  2020-05-08

10.  The transcriptional coregulator NAB2 is a target gene for the Wilms' tumor gene 1 protein (WT1) in leukemic cells.

Authors:  Helena Jernmark Nilsson; Giorgia Montano; Tove Ullmark; Andreas Lennartsson; Kristina Drott; Linnea Järvstråt; Björn Nilsson; Karina Vidovic; Urban Gullberg
Journal:  Oncotarget       Date:  2017-08-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.